Correlation between chest DW-MRI and 18F-FDG PET/CT in newly diagnosed non-small cell lung cancer (NSCLC)
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Correlation between chest DW-MRI and 18F-FDG PET/CT in newly diagnosed non-small cell lung cancer (NSCLC) ; volume:55 ; number:1 ; day:3 ; month:6 ; year:2024 ; pages:1-11 ; date:12.2024
The Egyptian Journal of Radiology and Nuclear Medicine ; 55, Heft 1 (3.6.2024), 1-11, 12.2024
- Urheber
-
Lotfy, Abeer Gamal
Abdou, Nora Nabil
Monib, Ahmed Mohamed
Hussein, Rasha S.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s43055-024-01284-1
- URN
-
urn:nbn:de:101:1-2408102129105.155495729355
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:44 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Lotfy, Abeer Gamal
- Abdou, Nora Nabil
- Monib, Ahmed Mohamed
- Hussein, Rasha S.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Anomaly detection in chest 18F-FDG PET/CT by Bayesian deep learning
Impact of 18F-FDG PET/CT, CT and EBUS/TBNA on preoperative mediastinal nodal staging of NSCLC
Prospektive Evaluation des Verhaltens der Tumorgewebe bei NSCLC in der FDG-PET unter Strahlentherapie (Response PET/CT)
Prognostic nomogram combining 18F-FDG PET/CT radiomics and clinical data for stage III NSCLC survival prediction
FDG PET/CT depicts cutaneous plasmocytoma
Role of 18F-FDG PET/CT in assessment of HCC patients after therapeutic interventions compared to DW MRI
Repeatability of [18F]FDG PET/CT total metabolic active tumour volume and total tumour burden in NSCLC patients
How We Read Oncologic FDG PET/CT
Metabolic patterns on [18F]FDG PET/CT in patients with unresectable stage III NSCLC undergoing chemoradiotherapy ± durvalumab maintenance treatment
Chemotherapy response evaluation in metastatic non-small cell lung carcinoma (NSCLC) with 18F- FDG PET/CT and CT scan
Rubidium Uptake in Chest Tumors on PET/CT
Amelanotic melanoma detected by 18F-FDG PET-CT
Anomaly detection in chest 18F-FDG PET/CT by Bayesian deep learning
Impact of 18F-FDG PET/CT, CT and EBUS/TBNA on preoperative mediastinal nodal staging of NSCLC
Prospektive Evaluation des Verhaltens der Tumorgewebe bei NSCLC in der FDG-PET unter Strahlentherapie (Response PET/CT)
Prognostic nomogram combining 18F-FDG PET/CT radiomics and clinical data for stage III NSCLC survival prediction
FDG PET/CT depicts cutaneous plasmocytoma
Role of 18F-FDG PET/CT in assessment of HCC patients after therapeutic interventions compared to DW MRI
Repeatability of [18F]FDG PET/CT total metabolic active tumour volume and total tumour burden in NSCLC patients
How We Read Oncologic FDG PET/CT
Metabolic patterns on [18F]FDG PET/CT in patients with unresectable stage III NSCLC undergoing chemoradiotherapy ± durvalumab maintenance treatment
Chemotherapy response evaluation in metastatic non-small cell lung carcinoma (NSCLC) with 18F- FDG PET/CT and CT scan
Rubidium Uptake in Chest Tumors on PET/CT
Amelanotic melanoma detected by 18F-FDG PET-CT
Anomaly detection in chest 18F-FDG PET/CT by Bayesian deep learning
Impact of 18F-FDG PET/CT, CT and EBUS/TBNA on preoperative mediastinal nodal staging of NSCLC
Prospektive Evaluation des Verhaltens der Tumorgewebe bei NSCLC in der FDG-PET unter Strahlentherapie (Response PET/CT)
Prognostic nomogram combining 18F-FDG PET/CT radiomics and clinical data for stage III NSCLC survival prediction
FDG PET/CT depicts cutaneous plasmocytoma
Role of 18F-FDG PET/CT in assessment of HCC patients after therapeutic interventions compared to DW MRI
Repeatability of [18F]FDG PET/CT total metabolic active tumour volume and total tumour burden in NSCLC patients
How We Read Oncologic FDG PET/CT
Metabolic patterns on [18F]FDG PET/CT in patients with unresectable stage III NSCLC undergoing chemoradiotherapy ± durvalumab maintenance treatment
Chemotherapy response evaluation in metastatic non-small cell lung carcinoma (NSCLC) with 18F- FDG PET/CT and CT scan
Rubidium Uptake in Chest Tumors on PET/CT